C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
12/2009
12/22/2009	US7635774 Benzimidazole derivatives
12/22/2009	CA2307879C Treatment of t-helper cell type 2 mediated immune diseases
12/22/2009	CA2290744C Cyclic diamine compounds and medicine containing the same
12/17/2009	WO2009126947A3 Heteroaryl-substituted bicyclic smac mimetics and the uses thereof
12/17/2009	US20090312384 Benzimidazole As Cooling Compounds
12/17/2009	US20090312383 Fused Heterocyclic Compounds
12/17/2009	US20090312380 Novel compositions and methods
12/17/2009	US20090312365 Certain Chemical Entities, Compositions, and Methods
12/16/2009	CN101605763A Radioprotector compounds and related methods
12/16/2009	CN101605757A (Indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity
12/16/2009	CN100569755C Benzimidazole-like heterocyclic compound and its intermediate synthesis method
12/15/2009	US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009	US7632578 Containing imidazo-pyridine compound
12/15/2009	CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors
12/10/2009	WO2008146172A3 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/10/2009	US20090306127 Certain Chemical Entities, Compositions and Methods
12/09/2009	EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2129663A2 Muscarinic receptor antagonists
12/09/2009	EP2129654A1 Novel antagonists of the glucagon receptor
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/09/2009	CN100567273C Organic compounds
12/09/2009	CN100567270C Sulfonyl amide derivatives
12/08/2009	US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009	CA2404725C Extrusion die
12/03/2009	WO2009106817A3 1 ibeta- hydroxysteroid dehydrogenase inhibitors
12/03/2009	US20090299074 BENZO[b]THIOPHEN DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
12/03/2009	US20090298828 Alkoxyalkyl-Substituted Cyclic Keto-Enols
12/03/2009	US20090298824 Organic compounds
12/03/2009	US20090298811 Benzimidazolone derivatives
12/03/2009	US20090298189 Hydrophobic Ionic Liquids
12/02/2009	EP2125753A1 Fused heterocyclic compounds having crf antagonistic activity
12/02/2009	EP2125752A1 Heterocyclic bridged biphenyls
12/02/2009	EP2125718A2 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
12/02/2009	EP1965805B1 Urea derivatives useful as calcium receptor modulators
12/02/2009	CN101591299A Side imidazolyl-containing benzidine derivatives and preparation method thereof
12/02/2009	CN101591298A Hydroxamic acid derivative containing 1,3-diazine five-membered bi-heterocyclic ring, preparation method and application thereof
12/01/2009	US7626033 Compounds for the modulation of PPARγ activity
12/01/2009	US7626031 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases
12/01/2009	US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction
12/01/2009	US7625889 Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
12/01/2009	CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009	US20090291989 Isothiocyanate compounds, pharmaceutical compositions, and uses thereof
11/25/2009	EP2121627A1 Benzimidazole derivatives
11/25/2009	EP2121626A1 Benzimidazole derivatives
11/25/2009	EP2121625A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/25/2009	EP2121624A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/25/2009	EP2121623A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/25/2009	EP2121622A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/25/2009	EP1853591B1 Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate
11/25/2009	EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
11/25/2009	EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009	EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009	CN100562516C Beta-amyloid protein production/secretion inhibitors
11/24/2009	US7622479 For example, 2-(1,3-benzodioxol-5-yl)-6-phenyl-1H-imidazo[4,5-b]pyridinetyrosine; kinase-inhibiting activity; use in treatment of breast cancer, prostate cancer, lung cancer or pancreatic carcinoma
11/24/2009	CA2433197C Gyrase inhibitors and uses thereof
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/24/2009	CA2368454C Novel carboxylic acid derivatives and process for producing the same
11/19/2009	WO2009139373A1 Amide compound
11/19/2009	WO2009139076A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/19/2009	WO2009074300A8 Hedgehog pathway antagonists and therapeutic applications thereof
11/19/2009	US20090286841 Certain chemical entities, compositions, and methods
11/19/2009	US20090286772 2-(Phenyl or Heterocyclic)-1H-Phenanthro[9,10-D]Imidazoles
11/19/2009	US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009	US20090284134 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device
11/19/2009	CA2724077A1 Amide compound
11/19/2009	CA2723455A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/18/2009	EP2118057A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity
11/18/2009	EP2117540A1 New use of glutaminyl cyclase inhibitors
11/18/2009	EP1996556B1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
11/18/2009	CN101583596A N-substituted-azacyclylamines as histamine-3 antagonists
11/18/2009	CN101583593A Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
11/18/2009	CN101580700A Chemical mechanical polishing composition
11/18/2009	CN101580521A Dendritic organic metal composition and electroluminescent device using same
11/17/2009	US7618993 Compounds
11/17/2009	US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009	CA2450801C Drugs that enhance synaptic responses mediated by ampa receptors
11/17/2009	CA2417082C New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
11/17/2009	CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/12/2009	WO2009116074A3 Substituted benzimidazoles as cannabinoid modulator
11/12/2009	WO2009115584A3 2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin ii antagonists
11/12/2009	US20090281307 Benzoimidazole compounds
11/12/2009	US20090281120 Bicyclic heterocyclic compound
11/12/2009	US20090281098 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase
11/12/2009	US20090278115 Nitrogen-containing heterocyclic derivative and organic electroluminescence element using the same
11/11/2009	EP2116534A1 Process for production of binuclear metal complex
11/11/2009	EP2116526A1 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors
11/11/2009	EP2114896A1 Radioprotector compounds and related methods
11/11/2009	EP2114156A1 Chemical compounds, pharmaceutical compositions and methods
11/11/2009	EP2019874B1 Porous metal organic framework based on pyrroles and pyridinones
11/11/2009	EP1566381B1 Process for production of 1- 2-(benzimidazol-2-yl- thio)ethyl piperazine or salts thereof
11/11/2009	CN101575317A Method for preparing 4,5,6,7-tetrahydro-1H-benzimidazo-5-methanoic acid derivatives
11/11/2009	CN100558712C Therapeutic molecules and methods-1
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/10/2009	CA2457952C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders
11/05/2009	WO2009133964A1 Agent for prevention of oxidative stress
11/05/2009	WO2009133122A1 Production of 1,7´-dimethyl-2´-propyl-2,5´-bi-1h-benzimidazole
11/05/2009	US20090275748 For example, 5-tert-Butyl-2-{2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions

1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 154